Last Updated: June 25, 2026

PHENDIMETRAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Phendimetrazine, and what generic alternatives are available?

Phendimetrazine is a drug marketed by Acertis Pharms, Graham Dm, Virtus, Sandoz, Vitarine, Barr, Chartwell, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mpp Pharma, Nexgen Pharma Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.

The generic ingredient in PHENDIMETRAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phendimetrazine

A generic version of PHENDIMETRAZINE was approved as phendimetrazine tartrate by CHARTWELL on October 30th, 1991.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PHENDIMETRAZINE?
  • What are the global sales for PHENDIMETRAZINE?
  • What is Average Wholesale Price for PHENDIMETRAZINE?
Summary for PHENDIMETRAZINE
US Patents:0
Applicants:24
NDAs:65
Drug Prices: Drug price information for PHENDIMETRAZINE
DailyMed Link:PHENDIMETRAZINE at DailyMed

US Patents and Regulatory Information for PHENDIMETRAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084141-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ferndale Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086834-001 Sep 15, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pvt Form PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085697-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.